Microbiome & Probiotic R&D and Business Collaboration Forum: USA 2026

Microbiome & Probiotic R&D and Business Collaboration Forum: USA 2026 is dedicated to the latest research into microbial communities with a focus on translation to therapeutics.

Key Topics

• Commercialization
  • Pharma and biotech case studies and strategies
  • Venture capital and funding options - start-up showcases
  • Going beyond the noise
  • QC, IP and regulatory angles
  • Partnering across the microbiome field - industry/academia
  • Development, application & acquisition of technology platforms within the microbiome space
• Gut Microbiome
  • Microbiome and cancer
  • Microbiome and IBD/IBS
  • Microbiome and early life
  • Interventions in the microbiome -phage/FMT/synthetic biology
  • Obesity and cardio-metabolic disease
• Probiotics and Prebiotics
  • Probiotics in paediatrics
  • Probiotics and digestive health
  • Strain identification, screenings and safety
  • Regulation and product development
  • Human milk oligosaccharides
  • Prebiotics, dietary fibre, personalized nutrition
• Outside the Gut
  • Women`s health - host-interactions, vaginal microbiome, preterm birth and pregnancy progression
  • Skin microbiome - acne, eczema, atopic dermatitis, probiotics, wound health & cosmetic applications
  • Lung and oral microbiome research
  • Gut-brain axis - signalling, role of human milk oligosaccharides & nutrition, links to disease and behaviour

Who should Attend

Attendees from:

• Academia
• Industry
• Investment
• Venture capital